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The eﬀects of glucocorticoids on both foetal canine lung and
endogenous serum cortisol concentration have not been clearly
delineated. Therefore, we aimed to investigate whether mater-
nal corticosteroid treatment can alter maternal and neonatal
cortisol proﬁle and improve neonatal vitality. We allocated six
bitches of diﬀerent breeds and their neonates into two groups:
control group (CONT) – maternal administration of saline
solution at 55 days post-ovulation (n = 3); and betamethasone
group (BETA) – administration of a single dose of 0.5 mg/kg
betamethasone (Celestone Soluspan®) at 55 days post-ovula-
tion (n = 3). Caesarean sections were scheduled for day 63
after ovulation. However, BETA group dams showed preco-
cious signs of labour, and c-sections were performed at
58 days post-ovulation. Maternal and neonatal evaluations
were performed periodically between betamethasone adminis-
tration and birth, respectively. Neonates from both groups
presented unsatisfactory (<5) Apgar score at birth. However,
in spite of an earlier improvement on vitality found on CONT
group and the premature delivery on BETA group, both
groups showed acceptable Apgar score 120 min after birth.
Neonatal cortisol concentrations were higher on CONT group
compared to BETA group at birth. In addition, a gradual
decrease on maternal cortisol concentrations was observed in
the BETA group from treatment until parturition. These
ﬁndings suggest that despite the down-regulation on the
hypothalamic-pituitary-adrenal axis and the induction of
premature delivery, betamethasone treatment was able to
provide similar vitality when compared to the untreated
neonates born at term.
Introduction
The physiological increase on endogenous cortisol
concentrations, days before labour, is of utmost impor-
tance for overall foetal ﬁnal maturation (Bonanno and
Wapner 2009). Previous study suggests the important
role of distinct endocrinological factors, including
glucocorticoids, on foetal pulmonary development of
several species, such as rodents, primates and human
(Bolt et al. 2001). On the other hand, during premature
labour, various adaptive mechanisms are delayed, and
these diminish neonatal survival likelihood. Of the
major pathological conditions of foetal immaturity,
the Respiratory Distress Syndrome (RDS) is one of the
most signiﬁcant, deriving from an impairment on
surfactant synthesis due to pulmonary immaturity.
Antenatal corticosteroid administration to pregnant
women, aiming to artiﬁcially induce pulmonary foetal
maturation, is a standard treatment in human medicine,
initially proposed in 1972 (Peltoniemi et al. 2007). Data
in newborn humans suggest that corticotherapy also
support the decrease in the incidence and severity of
other neonatal pathological conditions, such as necro-
tizing enterocolitis and periventricular leukomalacia.
Betamethasone is the drug of choice to improve
neonatal pulmonary function, with a greater bound
aﬃnity to the glucocorticoid receptor compared to
endogenous cortisol (Ballard and Ballard 1995).
According to the trial conducted by Liggins and Howier
(1972), a combination protocol with two forms of
betamethasone results in a rapid onset with betameth-
asone phosphate combined with a prolonged exposure
due to the slower hydrolysis of betamethasone acetate.
Even though antenatal corticotherapy is constantly
applied in human medicine, yet in some veterinarian
patients, there is still a need for consistent research to
establish the ideal protocol and therapeutic action,
allowing for the safe use without empirical basement. In
veterinary medicine, especially in dogs, no research has
been undertaken in relation to maternal or foetal
cortisol proﬁle after glucocorticoid administration, as
well as the inﬂuence of such drugs on neonatal vitality
improvement. Hence, the aims of the present study were
to investigate whether maternal corticosteroid treatment
can improve neonatal vitality and alter maternal and
neonatal endogenous cortisol proﬁle.
Materials and Methods
This study was approved by the Bioethics Committee of
the School of Veterinary Medicine and Animal Science
– USP (protocol no. 1672/2009). In this study, we used
six females of diﬀerent breeds (body weights from 15 to
20 kg; ages from 2 to 6 years) and 12 neonates (two
puppies per bitch), randomly allocated in the following
groups: Betamethasone (BETA) – maternal administra-
tion of a single dose of 0.5 mg/kg of maternal body
weight of betamethasone (Celestone Soluspan®, Merck
& Co., Inc., Whitehouse Station, NJ, USA) at 55 days
post-ovulation (n = 3 females and six neonates); and
Control (CONT) – maternal administration of saline
solution (0.9% NaCl) at 55 days post-ovulation (n = 3
females and six neonates). The prediction of parturition
date was based upon estimation of the LH peak and
ovulation from vaginal cytology, vaginoscopy and
progesterone concentration. The ovulation day was
considered to occur 48 hours after the LH surge, this
later determined through both progesterone and LH
assays.
C-sections were performed at 63 days post-ovulation
through the following anaesthetic protocol: sedation
with acepromazine (0.02 mg/kg, Acepran 0.2%®;
Vetnil, Louveira, Brazil), tramadol (2 mg/kg, Cloridrato
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de Tramadol®; Hipolabor, Belo Horizonte, Brazil) or
morphine (0.3 mg/kg, Sulfato de Morﬁna®; Hipolabor)
injected by the intramuscular route. Anaesthesia was
induced with slow intravenous administration of
propofol (1 mg/kg, Fresofol®; Fresenius Kabi, Bad
Homburg, Germany) and epidural blockage in the
lumbosacral intervertebral space using an association
of lidocaine chloride (2 mg/kg, Xylestesin®; Crista´lia,
Sa˜o Paulo, Brazil) and morphine (0.1 mg/kg, Dimorf®;
Crista´lia, Sa˜o Paulo, Brazil). General inhalational
anaesthesia was maintained with isoﬂuorane (Isoﬂur-
ano; BioChimico®, Rio de Janeiro, Brazil).
Maternal and neonatal analysis
Maternal venous blood samples were collected immedi-
ately prior to betamethasone or saline solution admin-
istration (55 days post-ovulation); 1 h after
betamethasone or saline solution administration
(55 days post-ovulation); and daily until parturition
(56–63 days post-ovulation), always during the same
time of day. After birth and neonatal resuscitation,
puppies were maintained in a neonatal incubator (Berc¸o
Aquecedor AQ50®; Fanem, Sa˜o Paulo, Brazil), which
allowed implementation of the experimental procedures.
Neonatal blood samples were collected from the right or
left jugular vein. Cortisol concentrations were deter-
mined immediately at birth (0 h) and 2 h (2 h) later.
The blood samples were allowed to clot at room
temperature and centrifuged for 10 min at 1500 g. The
serum was drawn oﬀ and stored at 20°C until analysis.
The neonatal vitality was veriﬁed using the Apgar
system adapted for canine neonates (Silva 2008) at the
following moments: at birth (0), at 5 min, at 60 min, at
2 h (120 min) and at 4 h (240 min) of life. To establish
the Apgar score (0–10), the heart (0–2) and the
respiratory (0–2) rates and eﬀort were evaluated. Fur-
thermore, the muscle tone (0–2) of each neonate was
appraised mainly by observing the neonate’s ability to
maintain strength at dorsal recumbency position; their
head movements were also evaluated. An irritability
reﬂex (0–2) was estimated from the neonate’s respon-
siveness to manipulation during the examination.
Finally, the colours of the mucous membranes (0–2) of
the gums were inspected to verify the presence of pallor
or cyanosis. For each of the referred variables, a score
from 0 to 2 was attributed, thus summarizing the Apgar
score ranging from zero to 10. The neonates’ rectal
temperatures were also recorded at the same moments in
which Apgar assessment was performed.
Serum cortisol concentrations were measured by
radioimmunoassay using a commercial kit (Cortisol
Coat-A-Count; Genese®, Sa˜o Paulo, Brazil), previously
validated for canine serum. Results were expressed as
lg/dl after conversion according to a calibration curve
simultaneously prepared. The sensitivity of the cortisol
assay at 92% binding was 0.11 lg/dl, and the low and
high intra-assay coeﬃcients of variation were 1.84%
and 1.21%, respectively.
Statistical analysis
Data were evaluated using Statistical Analysis System
(SAS®; SAS Institute Inc., Cary, NC, USA). The eﬀects
of treatment (CONT and BETA) and the evaluation
moment were estimated using PROC GLM. The diﬀer-
ences between the treatments were analysed using
parametric (the GLM procedure for each factor sepa-
rately or LSD when combining factors) and non-
parametric (Wilcoxon) tests, according to the residual
normality (Gaussian distribution) and variance homo-
geneity. Whenever necessary, the data were transformed
to obey these statistical assumptions. The diﬀerences
between treatment and time were analysed using PROC
NPAR1WAY and LSD test for multiple comparisons
for non-parametric and parametric variables, respec-
tively. The results were described as untransformed
means and standard deviations (mean ± SD). Statistical
diﬀerences were considered to have occurred if p < 0.05.
Results
Neonates from CONT group were born at 63 days after
ovulation, while BETA neonates had to be urgently
delivered at 58 days, as the treatment induced preco-
cious labour signs (such as restless, vaginal mucous
discharge, fall in body temperature and abdominal
contractions), approximately 76 h after administration.
Neonates of both groups presented similar unsatisfac-
tory (<5) Apgar score at birth (Table 1). However,
newborns from BETA group showed lower Apgar score
(9 ± 0.3) when compared to CONT group (10 ± 0)
240 min (4 h) postpartum (Table 1). Furthermore,
acceptable Apgar scores (>7) were achieved on the
CONT group neonates earlier than the BETA group
(60 min: 8.17 ± 0.70 vs 6.25 ± 0.75; and 120 min:
9.17 ± 0.4 vs 8.25 ± 0.63, respectively, Table 1). No
diﬀerences were found between groups on all evaluation
moments when variables used to calculate the Apgar
score (heart and respiratory rates, muscle tone,
Table 1. Means and standard deviations (mean ± SD) of the neonatal (n = 12) Apgar score (0–10) at 0, 5, 60, 120 and 240 min after birth for the
CONT and BETA groups
Group
Minutes after birth
0 5 60 120 240
CONT 4 ± 0.77C 5.5 ± 1.18B,C 8.17 ± 0.7A,B 9.17 ± 0.4A 10 ± 0*A
BETA 3 ± 0.41D 4.2 ± 0.48C,D 6.25 ± 0.75B,C 8.25 ± 0.63A,B 9 ± 0.26*A
CONT, control group, BETA, betamethasone group.
ABC Diﬀerent letters within the same row diﬀer signiﬁcantly (p < 0.05).
*Within the same column diﬀer signiﬁcantly (p < 0.05).
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irritability reﬂex and mucous colour) were considered
separately. Hypothermia was veriﬁed at 5 min post-
partum in both groups. A gradual increase in body
temperature occurred during periods of observation,
with diﬀerences between groups (Table 2).
Neonatal cortisol concentrations were higher in the
CONT group when compared to the BETA group only
at the moment of parturition (3.85 ± 0.56 and
0.17 ± 0.06 lg/dl, respectively; p = 0.0012, Table 3).
No diﬀerence was noticed among periods of analysis
within the same group (Table 3). Within groups,
maternal cortisol concentration diﬀered only 24 h after
betamethasone or saline injection (CONT:
14.1 ± 2.6 lg/dl and BETA: 1.1 ± 0 lg/dl; p = 0.037,
Table 4). Moreover, BETA group exhibited a gradual
decrease on cortisol concentrations from treatment until
parturition (pre-treatment: 10.3 ± 1.7 lg/dl; post-treat-
ment: 5.4 ± 1.3 lg/dl and delivery day: 1.1 ± 0 lg/dl,
Table 5).
Discussion
Cortisol, a corticosteroid hormone, is synthesized by the
adrenal glands. This hormone is regulated by the
anterior pituitary adrenocorticotropic hormone (ACTH)
which, in turn, is stimulated by the corticotrophin-
releasing hormone (CRH) secreted by the paraventric-
ular nucleus of the hypothalamus (Cunningham 2008).
The hypothalamic-pituitary-adrenal (HPA) axis is trig-
gered prior to parturition, but the timing of this event
varies by species and is not known in carnivores.
Maternal endogenous cortisol concentration decrease
within 2 h after betamethasone treatment followed by a
more pronounced drop after 12 h (Ballard et al. 1980).
In the present study, we veriﬁed that bitches treated with
betamethasone showed lower concentrations of cortisol
when compared to the control group 24 h after treat-
ment. Despite several beneﬁcial pulmonary eﬀects,
prenatal administration of betamethasone is recognized
to be transiently suppressive to foetal and maternal
adrenal cortex, as it inhibits the release of pituitary
ACTH. According to Ballard and Ballard (1995), foetal
cortisol concentration measured in the blood collected
from the umbilical cord presents a 50% decrease 6 h
after maternal corticotherapy. Corroborating such ﬁnd-
ings, we observed, at birth, higher concentrations of
neonatal endogenous cortisol in the CONT group when
compared to the animals delivered from bitches treated
with betamethasone (CONT: 3.85 ± 0.56 lg/dl and
BETA: 0.17 ± 0.06 lg/dl). These results may be associ-
ated with the suppressive inﬂuence of the corticosteroid
treatment on the HPA axis. Furthermore, the CONT
group presented the expected response to labour stress
with a decrease in cortisol concentration occurring
120 min after birth, while BETA group remained
unchanged.
Regarding the Apgar score analysis, neonates of BETA
group presented delayed vitality in comparison with
CONT group. Indeed, the Apgar score at 240 min of
birth was statistically lower in the treated group. In spite
of the premature labour, neonates of BETA group
accomplished adaptive capability and favourable clinical
condition after 2 h of life. Hence, maternal corticother-
apy was able to simulate the eﬀect of endogenous cortisol
on foetal maturation notwithstanding the adrenal sup-
pression at birth. In fact, Regazzi (2011) observed a
structural pulmonary maturation simultaneously to an
improvement on neonatal clinic condition in response to
canine prenatal betamethasone administration. There-
fore, the overall clinical recovery and neonatal favour-
able outcome at 58 days post-ovulation can be
exclusively attributed to maternal betamethasone treat-
ment.
We can conclude that maternal administration of
betamethasone at 0.5 mg/kg induced premature labour
with no long-term clinical negative eﬀects in canine
preterm neonates. Corticosteroid treatment induced
Table 2. Means and standard deviations (mean ± SD) of the neonatal
(n = 12) body temperature (°C) at 0, 5, 60, 120 and 240 min after birth
for CONT and BETA groups
Time after birth CONT group BETA group
At birth (0) 34.98 ± 0.63A 34.47 ± 0.58A
5 min 32.38 ± 0.37B 32.87 ± 0.25B
60 min 32.35 ± 0.43B 32.65 ± 0.23B
120 min 34.67 ± 0.31A 32.25 ± 0.27A
240 min 36.5 ± 0.73A 35.17 ± 0.23A
CONT, control group; BETA, betamethasone group.
Diﬀerent letters within the same column diﬀer signiﬁcantly (p < 0.05).
Table 3. Means and standard deviations (mean ± SD) of the neonatal
(n = 12) cortisol level (lg/dl) at 0 and 120 min after birth
Time CONT group BETA group
At birth (0) 3.85 ± 0.56* 0.17 ± 0.06*
120 min 1.94 ± 0.99 0.11 ± 0
CONT, control group; BETA, betamethasone group.
*Within the same row diﬀer signiﬁcantly (p < 0.05).
Table 4. Means and standard deviations (mean ± SD) of the maternal
(n = 6) cortisol concentration (lg/dl) before and after betamethasone
or saline solution injection for BETA and CONT groups, respectively
Time CONT group BETA group
Before injection (55 days post-ovulation) 22.93 ± 5.10 10.30 ± 1.66AB
1 h after injection 15.23 ± 4.34 12.23 ± 3.64A
24 h after injection 14.07 ± 2.59* 1.10 ± 0B*
CONT, control group; BETA, betamethasone group.
Diﬀerent letters within the same column diﬀer signiﬁcantly (p < 0.05).
*Within the same row diﬀer signiﬁcantly (p < 0.05).
Table 5. Means and standard deviations (mean ± SD) of the maternal
(n = 6) cortisol concentration (lg/dl) before and after betamethasone
or saline solution injection (average from daily samples from 55 to 62
days post-ovulation) for BETA and CONT groups, respectively
Time CONT group BETA group
Before injection (55 days after ovulation) 22.93 ± 5.10 10.30 ± 1.66A
After injection (55–62 days after ovulation) 13.78 ± 4.75 5.41 ± 1.33AB
At whelping day 14.37 ± 6.34 1.10 ± 0B
CONT, control group; BETA, betamethasone group.
Diﬀerent letters within the same column diﬀer signiﬁcantly (p < 0.05).
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labour onset and foetal maturation, especially in vital
organs. Despite the readily apparent foetal adrenal
suppression caused by maternal betamethasone, treated
neonates are responsive to the exogenous induction of
overall maturation.
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